Elon Musk’s start-up Neuralink on Thursday said it has approval from US regulators to test its brain implants in people. Neuralink said clearance from the US Food and Drug Administration (FDA) for its first in-human clinical study is “an important first step” for its technology, which is intended to let brains interface directly with computers.
